Solutions · Device Classification

Class I, II, or III?
Get a defensible answer in minutes.

Complizen analyzes your intended use and device characteristics, queries the FDA classification database, surfaces comparable cleared devices, and outputs a classification rationale document — cited and ready to defend to investors, FDA, and your quality system.

Classification ResultClass II
DeviceSingle-use RF ablation catheter
Product CodeKZH
Regulation21 CFR 870.3610
PathwayTraditional 510(k)
User Fee$24,320 (FY2025)
Special ControlsPerformance standards, biocompatibility, electrical safety
Classification rationale document ready to export
How it works

From device description to classification rationale in four steps.

01

Describe your device

Provide your intended use, patient population, and technological characteristics. Plain English — no regulatory jargon required.

02

Complizen searches

Superagent queries the FDA classification database, 510(k) history, and any relevant De Novo decisions simultaneously.

03

Review the output

Device class, product code, 21 CFR regulation, applicable special controls, user fee, and pathway — all with direct citations.

04

Export the rationale

A classification rationale document, formatted for your quality system or investor deck — ready in minutes, not weeks.

What you get

Not just a class number. A full rationale document.

Every classification Complizen produces comes with the supporting evidence — not just the answer, but the reasoning FDA and investors need to see.

  • Device class (I, II, or III) with 21 CFR citation
  • Product code and regulation number
  • Applicable special controls with source links
  • Submission pathway (510(k), De Novo, PMA, Exempt)
  • Current FDA user fee for selected pathway
  • Comparable cleared devices for context
  • Exportable classification rationale document
“We had our classification and regulatory pathway mapped within hours of getting started. Work that used to feel like the hardest part of the whole process suddenly wasn't.”
Ángel Enríquez
Ángel Enríquez, Ph.D.
Founder & CEO, EmboaMed
Get your classification

Class I, II, or III — in minutes.

Book a demo